Daisy Richardson
Director, Analytical Method Development of Biologics, Merck
Merck
Macedonia
Biography
As director of Analytical Method Development for the Biologics BioProcess Development group, Daisy Richardson is the first to admit her role is one that’s a bit more behind-the-scenes. “My parents, neither of whom are scientists, ask me all the time what I do,” she says with a laugh. “You never really think about drug quality and safety. People always assume there is some control over it, but they don’t realize the complexity behind it. But there’s this incredible intricacy behind the molecules in the vial or syringe of medicine they are receiving. It needs to be safe and consistent.” Daisy oversees a team which creates tests to monitor the quality of the medicines that Merck manufactures. “It’s a big responsibility,” she notes. “Sometimes these tests might have a lifetime of 20 or 30 years. So you need to have a vision to make sure Merck continues to make products which remain safe and consistent during that time span.”
Research Interest
Business
